Misinterpretation of United States Pharmacopeia Chapter <797>
Download in electronic PDF format for $65
Abstract: By now, all compounding pharmacists should be aware that United States Pharmacopeia Chapter <797> has been revised. However, the revisions are tedious to read and may be misinterpreted. This article discusses some of the misinterpreted revisions of United States Pharmacopeia Chapter <797> and clarifies the revisions on the topics of Terminology, The Compounder, Facilities and Environment, Personnel Cleansing and Garbing, Assigning Beyond-use Dates, and Testing. Compounders need to take a firm stand with these misinterpretations of United States Pharmacopeia Chapter <797> and educate those who are not thoroughly familiar with the document. Compounders need to be diligent in following these standards to prevent harm to the patients.
Related Keywords:
Linda F. McElhiney, PharmD, RPh, FIACP, FASHP, United States Pharmacopeia Chapter <797>, USP, compounded sterile preparations, compounding facilities, garb, beyond-use dates, contamination, testing
Related Categories:
ENVIRONMENTAL , STERILE PREPARATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS, PROFESSIONAL ISSUES
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 92
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Misinterpretation of United States Pharmacopeia Chapter <797>
McElhiney Linda F
|
Jan/Feb 2012
Pg. 6-10
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
|
May/Jun 2020
Pg. 180
|
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
|
Mar/Apr 2021
Pg. 115-124
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2008
Pg. 344-353
|
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William, Roth Abby
|
May/Jun 2017
Pg. 193-203
|
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
|
Jul/Aug 2018
Pg. 303-312
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|